The relation of serum potassium concentration with cardiovascular events and mortality in community-living individuals

Clinical Journal of the American Society of Nephrology

Volumn 12, Issue 2, 2017, Pages 245-252

  Hughes Austin, Jan M ^a   Rifkin, Dena E ^a,b,c   Beben, Tomasz ^c   Katz, Ronit ^d,e   Sarnak, Mark J ^f   Deo, Rajat ^g   Hoofnagle, Andy N ^e   Homma, Shunichi ^h   Siscovick, David S ⁱ   Sotoodehnia, Nona ^d   Psaty, Bruce M ^d,j   De Boer, Ian H ^d,e   Kestenbaum, Bryan ^d,e   Shlipak, Michael G ^k   Ix, Joachim H ^a,b,c  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF CALIFORNIA SAN DIEGO   (United States)

^c VA SAN DIEGO HEALTHCARE SYSTEM   (United States)

^d UNIVERSITY OF WASHINGTON SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF WASHINGTON   (United States)

^f TUFTS UNIVERSITY   (United States)

^g UNIVERSITY OF PENNSYLVANIA   (United States)

^h Och Spine at New York Presbyterian Hospitals   (United States)

ⁱ NEW YORK ACADEMY OF MEDICINE   (United States)

^j CENTER FOR HEALTH STUDIES   (United States)

^k VETERANS AFFAIRS MEDICAL CENTER   (United States)

more..

Author keywords

Atherosclerosis; Cardiovascular diseases; Demography; Diuretics; Epidemiology and outcomes; Ethnic groups; Glomerular filtration rate; Humans; Hyperkalemia; Mortality risk; Potassium; Proportional hazards models; Reference values; Renal insufficiency, chronic; Risk factors; Serum potassium

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; BETA ADRENERGIC RECEPTOR STIMULATING AGENT; CREATININE; CYSTATIN C; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; NONSTEROID ANTIINFLAMMATORY AGENT; POTASSIUM; POTASSIUM SPARING DIURETIC AGENT; THIAZIDE DIURETIC AGENT;

AGED; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUSE OF DEATH; COLORIMETRY; COMORBIDITY; ESTIMATED GLOMERULAR FILTRATION RATE; ETHNICITY; FEMALE; FOLLOW UP; HIGH RISK POPULATION; HUMAN; MALE; MICROALBUMINURIA; POTASSIUM BLOOD LEVEL; POTENTIOMETRY; SMOKING; SUDDEN CARDIAC DEATH; BLOOD; EPIDEMIOLOGY; GLOMERULUS FILTRATION RATE; HYPERKALEMIA; INDEPENDENT LIVING; MIDDLE AGED; MORTALITY; OBSERVATIONAL STUDY; UNITED STATES;

AGED; CARDIOVASCULAR DISEASES; CAUSE OF DEATH; DIURETICS; FEMALE; FOLLOW-UP STUDIES; GLOMERULAR FILTRATION RATE; HUMANS; HYPERKALEMIA; INDEPENDENT LIVING; MALE; MIDDLE AGED; OBSERVATIONAL STUDIES AS TOPIC; POTASSIUM; UNITED STATES;

EID: 85021210354     PISSN: 15559041     EISSN: 1555905X     Source Type: Journal    
DOI: 10.2215/CJN.06290616     Document Type: Article

References (25)

1. Ettinger PO, Regan TJ, Oldewurtel HA: Hyperkalemia, cardiac conduction, and the electrocardiogram: A review. AmHeart J 88: 360-371, 1974
2. Mattu A, Brady WJ, Robinson DA: Electrocardiographic manifestations of hyperkalemia. Am J Emerg Med 18: 721-729, 2000
3. Ohmae M, Rabkin SW: Hyperkalemia-induced bundle branch block and complete heart block. Clin Cardiol 4: 43-46, 1981
4. Spodick DH: Effects of severe hyperkalemia. Am Heart Hosp J 6: 68, 2008
5. An JN, Lee JP, Jeon HJ, Kim DH, Oh YK, Kim YS, Lim CS: Severe hyperkalemia requiring hospitalization: Predictors of mortality. Crit Care 16: R225, 2012
6. Phillips BM, Milner S, Zouwail S, Roberts G, Cowan M, Riley SG, Phillips AO: Severe hyperkalaemia: Demographics and outcome. Clin Kidney J 7: 127-133, 2014
7. Bild DE, Bluemke DA, Burke GL, Detrano R, Diez Roux AV, Folsom AR, Greenland P, Jacob DR Jr, Kronmal R, Liu K, Nelson JC, O’Leary D, Saad MF, Shea S, Szklo M, Tracy RP: Multi-Ethnic Study of Atherosclerosis: Objectives and design. Am J Epidemiol 156: 871-881, 2002
8. Fried LP, Borhani NO, Enright P, Furberg CD, Gardin JM, Kronmal RA, Kuller LH, Manolio TA, Mittelmark MB, Newman A, O’Leary D, Psaty BM, Rautaharju P, Tracy RP, Weiler PG: The Cardiovascular Health Study: Design and rationale. Ann Epidemiol 1: 263-276, 1991
9. Cushman M, Cornell ES, Howard PR, Bovill EG, Tracy RP: Laboratory methods and quality assurance in the Cardiovascular Health Study. Clin Chem 41: 264-270, 1995
10. Meigs JB, Muller DC, Nathan DM, Blake DR, Andres R; Baltimore Longitudinal Study of Aging: The natural history of progression fromnormal glucose tolerance to type 2 diabetes in the Baltimore Longitudinal Study of Aging. Diabetes 52: 1475-1484, 2003
11. Ives DG, Fitzpatrick AL, Bild DE, Psaty BM, Kuller LH, Crowley PM, Cruise RG, Theroux S: Surveillance and ascertainment of cardiovascular events. The Cardiovascular Health Study. Ann Epidemiol 5: 278-285, 1995
12. Bluemke DA, Kronmal RA, Lima JA, Liu K, Olson J, Burke GL, Folsom AR: The relationship of left ventricular mass and geometry to incident cardiovascular events: The MESA (Multi-Ethnic Study of Atherosclerosis) study. J Am Coll Cardiol 52: 2148-2155, 2008
13. Agarwal I, Glazer NL, Barasch E, Biggs ML, Djoussé L, Fitzpatrick AL, Gottdiener JS, Ix JH, Kizer JR, Rimm EB, Siscovick DS, Tracy RP, Zieman SJ, Mukamal KJ: Fibrosis-related biomarkers and risk of total and cause-specific mortality: The Cardiovascular Health Study. Am J Epidemiol 179: 1331-1339, 2014
14. Deo R, Katz R, de Boer IH, Sotoodehnia N, Kestenbaum B, Mukamal KJ, Chonchol M, Sarnak MJ, Siscovick D, Shlipak MG, Ix JH: Fibroblast growth factor 23 and sudden versus non-sudden cardiac death: The Cardiovascular Health Study. AmJ KidneyDis 66: 40-46, 2015
15. Psaty BM, Lee M, Savage PJ, Rutan GH, German PS, Lyles M; The Cardiovascular Health Study Collaborative Research Group: Assessing the use of medications in the elderly: Methods and initial experience in the Cardiovascular Health Study. J Clin Epidemiol 45: 683-692, 1992
16. Inker LA, Schmid CH, Tighiouart H, Eckfeldt JH, Feldman HI, Greene T, Kusek JW, Manzi J, Van Lente F, Zhang YL, Coresh J, Levey AS; CKD-EPI Investigators: Estimating glomerular filtration rate from serum creatinine and cystatin C. N Engl J Med 367: 20-29, 2012
17. Lunn M, McNeil D: Applying Cox regression to competing risks. Biometrics 51: 524-532, 1995
18. Eilers PH, Marx BD: Flexible smoothing with B-splines and penalties. Stat Sci 11: 89-102, 1996
19. Rothman KJ: No adjustments are needed for multiple comparisons. Epidemiology 1: 43-46, 1990
20. Fang J, Madhavan S, Cohen H, Alderman MH: Serum potassium and cardiovascular mortality. J Gen Intern Med 15: 885-890, 2000
21. Walsh CR, Larson MG, Leip EP, Vasan RS, Levy D: Serum potassium and risk of cardiovascular disease: The Framingham Heart Study. Arch Intern Med 162: 1007-1012, 2002
22. Sica DA, Struthers AD, Cushman WC, Wood M, Banas JS Jr, Epstein M: Importance of potassium in cardiovascular disease. J Clin Hypertens (Greenwich) 4: 198-206, 2002
23. Alfonzo AV, Isles C, Geddes C, Deighan C: Potassium disorders-clinical spectrum and emergency management. Resuscitation 70: 10-25, 2006
24. Liao F, Folsom AR, Brancati FL: Is low magnesium concentration a risk factor for coronary heart disease? The Atherosclerosis Risk in Communities (ARIC) Study. Am Heart J 136: 480-490, 1998
25. Qu X, Jin F, Hao Y, Li H, Tang T, Wang H, Yan W, Dai K: Magnesium and the risk of cardiovascular events: A meta-analysis of prospective cohort studies. PLoS One 8: e57720, 2013